Home
>
National Drug Code (NDC)
>
Doxazosin
Doxazosin - 50436-6311-1 - (Doxazosin Mesylate)
Drug Information of Doxazosin
| Product NDC: | 50436-6311 |
| Proprietary Name: | Doxazosin |
| Non Proprietary Name: | Doxazosin Mesylate |
| Active Ingredient(s): | 8 mg/1 & nbsp; Doxazosin Mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Doxazosin
| Product NDC: | 50436-6311 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075536 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20001020 |
Package Information of Doxazosin
| Package NDC: | 50436-6311-1 |
| Package Description: | 30 TABLET in 1 BOTTLE (50436-6311-1) |
NDC Information of Doxazosin
| NDC Code | 50436-6311-1 |
| Proprietary Name | Doxazosin |
| Package Description | 30 TABLET in 1 BOTTLE (50436-6311-1) |
| Product NDC | 50436-6311 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Doxazosin Mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20001020 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | DOXAZOSIN MESYLATE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
